Provided by Tiger Trade Technology Pte. Ltd.

Mainz Biomed B.V.

0.8441
0.0000
Volume:- -
Turnover:4.82M
Market Cap:7.65M
PE:-0.10
High:0.8441
Open:0.8441
Low:0.8441
Close:0.8441
52wk High:5.34
52wk Low:0.5476
Shares:9.06M
Float Shares:8.30M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3903
EPS(LYR):-22.3610
ROE:-465.82%
ROA:-114.35%
PB:3.03
PE(LYR):-0.04

Loading ...

BUZZ-Mainz Biomed to rebrand as Quantum Cyber, shares rise

Reuters
·
Mar 11

Mainz Biomed Rebrands as Quantum Cyber, Reshapes Leadership

TIPRANKS
·
Mar 11

Mainz Biomed Nv - Plans Name Change to Quantum Cyber and Ticker Change to Qucy on March 12, 2026

THOMSON REUTERS
·
Mar 11

Press Release: Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Dow Jones
·
Mar 11

Mainz Biomed NV Files Initial Beneficial Ownership Statement for Director David E. Lazar

Reuters
·
Mar 03

Mainz Biomed to Present Blood-Based mRNA Biomarker Data at Digestive Disease Week 2026 Pancreatic Cancer Session

Reuters
·
Feb 24

Mainz Biomed NV Files Initial Beneficial Ownership Statement for Director Hans Hekland

Reuters
·
Feb 20

Mainz Biomed Secures $6 Million in Private Placement

Reuters
·
Feb 17

Press Release: Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Dow Jones
·
Feb 17

Mainz Biomed completes ATM share sales, retains capacity

TIPRANKS
·
Feb 11

Mainz Biomed NV Files Initial Statement of Beneficial Ownership for CEO and Director Guido Baechler

Reuters
·
Jan 27

Massive Insider Move: Major Investor Makes Colossal Bet on Mainz Biomed

TIPRANKS
·
Jan 17

Mainz Biomed NV Files Initial Beneficial Ownership Statement; Kevin Donahue Listed as 10% Owner

Reuters
·
Jan 17

Mainz Biomed Unveils Pancreatic Cancer mRNA Blood Test Study Results at AACR 2026

Reuters
·
Jan 14

Mainz Biomed Provides Review of 2025 Highlights

GlobeNewswire
·
Jan 05

Mainz Biomed Secures State Funding for Pancreatic Cancer Detection Project

Reuters
·
Jan 05

Mainz Biomed NV Partners with DoctorBox to Offer Home DNA Colorectal Cancer Test

Reuters
·
Dec 02, 2025

Mainz Biomed Signs MOU with OncoVanguard8 to Launch ColoAlert in South America

Reuters
·
Nov 18, 2025

Mainz Biomed NV Showcases Cancer Detection Solutions at MEDICA

Reuters
·
Nov 12, 2025

Mainz Biomed NV to Attend Annual Gastroenterological Working Group of Rhineland-Palatinate Meeting

Reuters
·
Nov 10, 2025